VolitionRx announced on Wednesday that it will present at the 9th annual Biotech Showcase Conference being held from January 9-11 in San Francisco, CA
Limited (NYSEMKT:VNRX) announced on Wednesday that it will present at the 9th annual Biotech Showcase Conference being held from January 9-11 in San Francisco, CA.
At the Biotech Showcase, Reynolds, Chief Executive Officer of Volition, will provide an update on Volition's business, clinical, regulatory and operational milestones, as well as the company's recently announced product launch of its Nu.QTM Colorectal Cancer Screening Triage Test.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of VolitionRx named herein, including the promotion by the Company of VolitionRx in any Content on the Site, the Company receives from said issuer...
FOR OUR FULL DISCLAIMER CLICK HERE